EEG Monitoring for Refractory Status Epilepticus — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

EEG Monitoring for Refractory Status Epilepticus — Stella

Recruiting

Back to Status Epilepticus trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United Kingdom

Royal London Hospital, London

Key details

Sponsor

Barts & The London NHS Trust

Enrollment target

~40 participants

Started

March 2020

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

16 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov